how many people are on glp-1 drugs in the us Market Size to Hit USD 132.79 Bn by 2035 The next 40 million GLP-1

doi: 10.2337/diacare.27.11.2628 [DOI] [PubMed] [Google Scholar] 213

Orlistat Generally safe but causes gastrointestinal side effects (e.g., oily spotting, flatus, fecal urgency), which often lead to discontinuation

Given that pregnancy is known to increase intestinal length (24), it would be reasonable to anticipate a corresponding increase in the total L-cell population during pregnancy, as reported in a previous mouse study (19)

Real-world observational studies examining clinical data have not identified consistent patterns of increased rates of general vision problems associated with GLP-1 use, though most studies were not specifically designed to detect rare ocular events

Differential hypothalamic neuronal activation following peripheral injection of GLP-1 and oxyntomodulin in mice detected by manganese enhanced magnetic resonance imaging

SGLT2is decrease plasma glucose levels through inhibition of renal glucose reabsorption in the proximal tubule, which results in increased glucose excretion by the kidneys